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The past few years have seen a shift in the use of Drosophila, from studies of growth and develop-
ment toward genetic characterization of carbohydrate, sterol, and lipid metabolism. This research,
reviewed below, establishes a new foundation for using this simple genetic model system to define
the basic regulatory mechanisms that underlie metabolic homeostasis and holds the promise of
providing new insights into the causes and treatments of critical human disorders such as diabetes
and obesity.Drosophila as a System for Studies of Metabolism
The multicellular complexity of higher organisms imposes
unique demands, requiring that animals sense their nutri-
tional status and respond in a concerted manner to coor-
dinate growth and maintain energy homeostasis. As a
result, metabolic regulation and physiological feedback
systems are central to all aspects of postembryonic life,
balancing energy needs with dietary input, contributing
to the timing of sexual maturation, influencing adult fertil-
ity, and acting as a key determinate of aging. Consistent
with these pervasive roles in development and physiology,
metabolic dysfunction is associated with major human
diseases, including diabetes, cardiovascular disease,
and some forms of cancer. Although largely assumed to
be an affliction of wealthy societies with abundant food
supplies, obesity has expanded to worldwide proportions,
with theWorld Health Organization estimating that at least
300 million adults are clinically obese. This increasing
impact on human health has resulted in a resurgence of
interest in understanding the mechanisms that underlie
metabolic control, often depending on mouse models to
study key metabolic disorders. Remarkably, however, rel-
atively little has been done to exploit the power of simple
genetic model systems to define the central mechanisms
that coordinate metabolic responses. In this review, we
focus on the status of such studies in the fruit fly,Drosoph-
ila melanogaster, with an emphasis on howDrosophila has
been used to define key aspects of metabolic control that
are conserved through evolution—providing new insights
that were not evident from studies of more complex verte-
brate systems.
Drosophila share most of the same basic metabolic
functions found in vertebrates. As discussed inmore detail
below, the fly maintains appropriate circulating sugar
levels, compensating for changing environmental condi-
tions and storing excess energy in the forms of glycogen
and lipid. These reserves are mobilized during periods of
energy need, such as exercise or nutrient depletion (Rus-
ten et al., 2004; Scott et al., 2004; Wigglesworth, 1949).
Many of the analogous organ systems that control nutrientuptake, storage, andmetabolism in humans are present in
the fruit fly. Digestion and nutrient absorption occur in the
Drosophila midgut, the functional equivalent of the stom-
ach and intestine. The fat body acts like the mammalian
liver and white adipose tissue, metabolizing nutrients
and storing large reserves of glycogen and lipid. Lipids
are carried through the circulatory system as either high-
density or low-density lipophorin particles (Canavoso
et al., 2001). Specialized clusters of Drosophila cells, the
oenocytes, accumulate lipids upon starvation and are
proposed to perform hepatocyte-like functions in lipid
processing (Gutierrez et al., 2007). In addition, separate,
discrete clusters of cells maintain insect carbohydrate
homeostasis in a manner analogous to the pancreatic
a and b cells (Lee and Park, 2004; Rulifson et al., 2002).
The central pathways of intermediary metabolism and
regulators of homeostasis are present in the fly, demon-
strating that most essential metabolic functions have
been conserved through evolution (Table S1). A key differ-
ence between mammalian and insect metabolism is the
inability of insects to synthesize cholesterol, rendering
them cholesterol auxotrophs (Gilbert et al., 2002). Impor-
tantly, however, this divergence does not mean that
Drosophila cannot be used for studies of cholesterol
metabolism, as described in more detail below for studies
of the Niemann Pick Type C (NPC) disease genes.
The relative ease of growing large numbers of Drosoph-
ila larvae or adults overcomes the disadvantage of their
small size, allowing researchers to use many of the
same basic assays to score metabolic function. These
include measurements of mitochondrial activity, ATP
assays, lipid metabolic profiling, insulin tolerance tests,
assays for the main stored form of lipid, triacylglycerol
(TAG), as well as both whole animal and circulating sugar
levels. Elegant assays for specific metabolic responses
are also possible in Drosophila that cannot be performed
inmore complex vertebrate systems, such as aGFP assay
for membrane-associated PIP3 in intact tissues, a hall-
mark of activated phosphoinositide-3-kinase (PI3K) sig-
naling (Britton et al., 2002), or a GFP reporter that can beCell Metabolism 6, October 2007 ª2007 Elsevier Inc. 257
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spatial patterns of SREBP activation (Kunte et al., 2006).
In this review, we surveymajormetabolic responses that
are conserved between flies and humans, emphasizing
how studies in Drosophila have provided new insights into
how these pathways are regulated (Table 1). To restrict
our survey, we focus on papers that use direct assays of
metabolic function to characterize mutant phenotypes,
and exclude papers that cover the regulation of growth by
insulin signaling or genetic studies of aging, both of which
have been reviewed elsewhere (Edgar, 2006; Helfand and
Rogina, 2003; Partridge and Gems, 2002). The picture
that emerges from the papers described below is the
dawnof a newera inDrosophilabiology—where this simple
genetic system is being increasingly exploited to define the
central pathways that control metabolism and physiology,
with implications for improving our understanding of how
homeostasis is maintained in all higher organisms and the
causes of metabolic disorders in humans.
Drosophila as a New Genetic Model for Diabetes
The conserved insulin/IGF pathways play a central role in
growth andmetabolism in higher organisms. In mammals,
IGFs primarily regulate growth, while insulin functions
mainly in glucose homeostasis. These two activities are
unified in the fly into a single insulin/IGF pathway. Seven
insulin-like peptides (DILP1–7), the functions of which
have not been completely elucidated (Brogiolo et al.,
2001; Ikeya et al., 2002), act through the Drosophila
insulin-like receptor (InR) to initiate a cascade of intracel-
lular events mediated by conserved components of the
insulin/IGF pathway. These include the insulin receptor
substrate (IRS) Chico, the insulin signaling antagonist
PTEN, PI3K, PKB/Akt kinase, and the single FOXO
ortholog dFOXO (reviewed by Oldham and Hafen, 2003)
(Figure 1).
Pioneering studies from a few labs have provided excit-
ing new insights into how DILPs regulate carbohydrate
metabolism in Drosophila. Under normal feeding condi-
tions, three dilp genes (dilp2, dilp3, and dilp5) are
expressed in small clusters of median neurosecretory
cells within the brain (Brogiolo et al., 2001; Broughton
et al., 2005; Ikeya et al., 2002). The expression of dilp3
and dilp5 is reduced in these insulin-producing cells
(IPCs) in response to lower dietary carbohydrate levels
but not amino acid starvation, indicating that dilp levels
can respond to specific nutritional cues much like insulin
in humans (Colombani et al., 2003; Ikeya et al., 2002).
Moreover, IPC ablation results in diabetic phenotypes,
with animals exhibiting a significant increase in circulating
glucose and trehalose (a disaccharide that is the primary
blood sugar in insects), as well as a moderate increase
in stored lipid (Broughton et al., 2005; Rulifson et al.,
2002). The IPCs appear to function like pancreatic b cells
in that they directly contact the heart and thus could
release DILPs into the circulatory system to maintain
appropriate levels of circulating sugars, although the
regulation of DILP secretion by IPCs remains unknown
(Rulifson et al., 2002).258 Cell Metabolism 6, October 2007 ª2007 Elsevier Inc.Similar to the release of glucagon from pancreatic
a cells in mammals, insect adipokinetic hormone (AKH)
counterbalances the actions of insulin by activating gly-
cogen phosphorylase, reducing fat body glycogen and
increasing circulating sugars (Gade and Auerswald,
2003; Kim and Rulifson, 2004; Lee and Park, 2004). Akh
is expressed exclusively in the corpora cardiaca (CC)
region of the ring gland, the main endocrine organ of
the insect (Lee and Park, 2004; Noyes et al., 1995), with
direct contacts to the IPCs and heart (Kim and Rulifson,
2004). Removal of Akh function by CC-specific cell abla-
tion results in a dramatic decrease in circulating treha-
lose, with no significant effect on glucose or stored lipid
levels (Isabel et al., 2005; Kim and Rulifson, 2004; Lee
and Park, 2004). In addition, ectopic Akh expression in
its primary target tissue, the fat body, results in hyper-
trehalosemia and a reduction of stored lipid through in-
creased lipolysis (Lee and Park, 2004). Stimulated release
of AKH by the CC is intimately linked to circulating sugar
levels through an inverse change in intracellular calcium
stores that is mediated by ATP-sensitive potassium
(KATP) channels, similar to the mechanisms that control
glucagon secretion by pancreatic a cells (Kim and Rulif-
son, 2004). Importantly, this regulated process is sensi-
tive to treatment with sulphonylureas, drugs that are
used for treating type 2 diabetes through their effects
on KATP channels. These studies demonstrate that the
central regulatory functions of insulin and glucagon are
conserved through evolution and establish Drosophila
as a valid model system for functional studies of glucose
homeostasis and the mechanisms that underlie the onset
of diabetes.
Metabolic Functions of TOR Signaling
The target of rapamycin (TOR) signaling pathway
responds to cellular levels of amino acids and ATP through
its upstream effectors, the tuberous sclerosis complex
(TSC1 and TSC2) and Rheb GTPase. TOR signaling,
together with complex regulatory interactions with the
insulin pathway, directs critical changes in cellular physiol-
ogy that link growth, translation, and autophagy to the
nutrient status of the animal (for reviews, see Edgar,
2006; Hay and Sonenberg, 2004). For example, TOR
kinase is active in the presence of sufficient nutrients,
phosphorylating S6 kinase (S6K), driving protein syn-
thesis, and facilitating growth (Figure 1). In addition, Akt-
mediated phosphorylation of a key transcriptional effector
of insulin signaling, FOXO, renders it inactive by res-
tricting it to the cytoplasm (Figure 1). In contrast, TOR
activity is reduced under starvation conditions, leading
to decreased translational capacity. Nonphosphorylated
FOXO translocates into the nucleus, triggering a transcrip-
tional program that includes the upregulation of 4E-BP,
which controls lipid mobilization (Figure 1) (Teleman
et al., 2005a). A recently described hypomorphic dTOR
allele results in reduced fat body lipid levels, increased
b hydroxybutyrate (indicative of increased conversion of
lipids into ketone bodies), and reduced glucose levels,
providing a new genetic system to better characterize
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ReviewTable 1. Summary of DrosophilaMetabolic Mutants
Loss of Function Gain of Function / Overexpression
Gene
Human Ortholog(s)/
Functional Homolog Starvation Lipids Sugar Starvation Lipids Sugar References
dilp 2,3,5 A insulin/IGFs resistant [ [ (Broughton et al., 2005;
Rulifson et al., 2002)
chico IRS1-4 [ no effect (Bohni et al., 1999)
dFOXO FOXO1, 3a, 4 [ [ (Luong et al., 2006)
Akh A glucagon resistant no effect Y Y [ (Gro¨nke et al., 2007;
Isabel et al., 2005;
Kim and Rulifson, 2004;
Lee and Park, 2004)
akhr resistant [ Y (Gro¨nke et al., 2007)




(Gro¨nke et al., 2005)
Lsd2 Perilipin/ADRP sensitive Y resistant [ (Gro¨nke et al., 2003;




resistant [ Yglycogen Y (Hader et al., 2003;
Teague et al., 1986)
melted HGNC/KIAA1692 Y no effect (Teleman et al., 2005b)
dTOR* TOR no effect Y Y (Luong et al., 2006;
Teleman et al., 2005b)
4E-BP 4E-BP sensitive Y [ (Teleman et al., 2005a)
Lk6 Mnk1/Mnk2 resistant [ resistant [ (Reiling et al., 2005)
dSREBP SREBP-1a/SREBP-2 FAsY (Kunte et al., 2006)
enigma Acyl-CoA
dehydrogenases
Y (Mourikis et al., 2006)
miR-14 [ Y (Xu et al., 2003)
miR-278 Y [ (Teleman et al., 2006)
expanded FERM domain
proteins
Y (Teleman et al., 2006)





dATF-2 i NPDC-1 sensitive Y no effect resistant [ (Okamura et al., 2007)
desat1* SCD1 Y (Ueyama et al., 2005)







VLCFAs[ (Min and Benzer, 1999)
NPC1a NPC1 chol. [ (Fluegel et al., 2006)
NPC1b NPC1L1 Y chol.
absorp.
(Voght et al., 2007)
Effects of loss-of-function and gain-of-function or overexpression studies are summarized with regard to starvation responses and
levels of lipids or carbohydrates (sugar). Lipids refers to TAG, except as listed. Genes include those covered in the text as well as
enigma, dUCP5, dATF-2, desat1, Cyp4g1, swiss cheese, and bubblegum, which were not discussed. The human sequence ortho-
log, or functional homolog, is listed for each gene. A, ablated tissue of expression; *, hypomorphic allele; i, RNAi knockdown; blank
cells, not determined.Cell Metabolism 6, October 2007 ª2007 Elsevier Inc. 259
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ReviewFigure 1. Schematic Representation of Signaling Pathways that Regulate Drosophila Metabolism
Functional interactions described in the text are depicted for a fat body cell under both fed and starved conditions. Solid lines and arrows represent
signaling interactions, while dotted lines and arrows represent regulatory effects that occur in the absence of that signaling pathway. In the fed
condition (top), DILPs and nutrients signal through the insulin and TOR pathways, respectively, resulting in retention of FOXO in the cytoplasm
and increased translation, driving growth. Sugars and fatty acids are stored as glycogen and TAG, while energy-producing metabolic pathways
are downregulated. In starved animals (bottom), insulin and TOR signaling is attenuated, directing FOXO nuclear translocation and reducing protein
synthesis, restricting growth. Glycogen and TAG are mobilized by AKH and lipases such as Brummer, while energy-producing metabolic pathways
are upregulated. See text for more details.260 Cell Metabolism 6, October 2007 ª2007 Elsevier Inc.
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Reviewthe effects of TOR signaling on energy metabolism (Luong
et al., 2006).
Although amino acid levels are known to modulate TOR
activity, the mechanisms that underlie this response
remain poorly understood. Genetic characterization of
the Slimfast amino acid transporter has provided some
initial clues into this pathway, indicating that it functions
as a nutrient sensor in the larval fat body, controlling a
systemic response that links amino acid levels with organ-
ismal growth (Colombani et al., 2003). The observation
that fat body-specific inactivation of either slimfast or
dTOR leads to similar phenotypes supports the proposal
that Slimfast can signal through dTOR in the fat body to
globally regulate growth and metabolism in response to
amino acid levels. This fat body amino acid sensor path-
way can override insulin signaling in peripheral tissues
through inhibition of PI3K activity, apparently through
one or more unidentified factors that emanate from the
fat body (Figure 1).
A genetic screen for growth regulators in Drosophila
revealed a new member of the TOR signaling pathway,
melted (Teleman et al., 2005b). This gene encodes a
protein with a pleckstrin homology (PH) domain that is
essential for its function. Melted can bind TSC1 and recruit
the TSC1/2 complex to cell membranes, suggesting it can
act upstream of TOR.meltedmutants have reduced lipids
but display no apparent defects in circulating sugar levels.
Although the mechanisms remain unclear, Melted may
help to facilitate the phosphorylation of dFOXO and
TSC2 by Akt in response to insulin input. Consistent with
the proposal that Melted limits the dFOXO response, the
dFOXO target 4E-BP is highly upregulated in starved
meltedmutants, and reduced dFOXO levels can suppress
the lipid metabolic defects of melted mutants. The identi-
fication of melted homologs in C. elegans, mice, and
humans sets the stage for further studies to understand
its role in TOR and FOXO signaling as well as lipid
metabolism.
Based largely on studies in cultured cells, 4E-BP has
been thought to mediate the growth effects of TOR
through direct inhibition of protein synthesis (Hay and
Sonenberg, 2004; Oldham and Hafen, 2003). Recent
Drosophila genetic studies, however, have challenged
this model. Loss-of-function and gain-of-function studies
have demonstrated that 4E-BP has no effect on growth
(Teleman et al., 2005a). Rather, 4E-BP mutant flies are
sensitive to starvation and display a significant decrease
in stored lipids upon prolonged starvation. Conversely,
animals expressing a constitutively active form of 4E-BP
display increased total lipid levels. This role for 4E-BP
is consistent with the lipid metabolic defects seen in
4E-BP mutant mice (Tsukiyama-Kohara et al., 2001). In
addition, Drosophila Lk6 mutants display elevated lipid
levels, consistent with the role of Lk6 in opposing the in-
hibitory effect of 4E-BP (Reiling et al., 2005). These studies
confirm the critical importance of genetic studies in
animals to test models derived from cultured cells and
provide a basis for characterizing the mechanisms by
which FOXO and TOR signaling regulate homeostasis.Regulation of Metabolism by SREBP
and microRNAs
A few studies, including those on the sterol regulatory
element binding proteins (SREBPs) and two miRNAs dis-
cussed below, have begun to address themechanisms by
which trans-acting factors controlDrosophilametabolism.
SREBPs play a critical role in maintaining unsaturated
fatty acid and cholesterol levels inmammalian cells. These
transcription factors reside as integral membrane proteins
in the endoplasmic reticulum. When sterol concentrations
drop inside the cell, the sterol-binding protein SCAP di-
rectly facilitates SREBP transport to the Golgi complex,
where SREBP is cleaved. The DNA-binding component
of SREBP can then translocate to the nucleus and induce
cholesterol biosynthetic gene expression, defining an
elegant feedback loop for maintaining cholesterol ho-
meostasis (Brown and Goldstein, 1997). The discovery of
an SREBP ortholog in flies, dSREBP, along with dSCAP
and two SREBP proteases, raises the interesting possibil-
ity that aspects of this feedback circuit have been main-
tained through evolution (Seegmiller et al., 2002). Studies
in Drosophila tissue culture cells confirmed this proposal,
showing that the major phospholipid in Drosophila, phos-
phatidylethanolamine, regulates dSREBP processing and
controlsmembrane lipid production (Dobrosotskaya et al.,
2002). Significantly, however, dSREBP does not respond
to cholesterol, consistent with the inability of Drosophila
to synthesize cholesterol.
Genetic studies of a dSREBP mutant have provided
insights into its roles in the animal (Kunte et al., 2006).
dSREBP null mutants die as undersized second instar lar-
vae and display reduced levels of fatty acids, although the
relative proportions of major long chain fatty acids remain
unchanged. Consistent with this phenotype, the authors
found reduced expression of three fatty acid synthesis
genes in dSREBP mutants, and adding soy lipids or spe-
cific long-chain fatty acids to the growth medium was
sufficient to rescue lethality. The authors designed
a dSREBP-GFP reporter system to monitor the spatial
and temporal patterns of dSREBP transcriptional activity
in the animal, showing that it is normally active in the fat
body, midgut, and oenocytes of feeding larvae. Impor-
tantly, this activity can be suppressed by adding excess
lipid to the diet, demonstrating that the reporter is subject
to normal feedback control. It will be interesting to ex-
amine other metabolic parameters in dSREBP mutants,
such as glucose and lipid levels, as well as identify direct
transcriptional targets that provide a better mechanistic
framework for understanding its roles in lipid physiology.
Two papers on DrosophilamiRNAs have demonstrated
important roles for these small RNAs in the posttranscrip-
tional control of lipid metabolism. In addition to its role in
cell death, miR-14 is required for a normal adult lifespan
and proper lipid levels (Xu et al., 2003). miR-14 mutants
have increased levels of TAG and the main circulating lipid
diacylglycerol (DAG) and have enlarged lipid droplets in
their adult fat, while animals carrying four copies of miR-
14 display an opposite phenotype. Levels of the major
fatty acid classes do not appear to be altered in miR-14Cell Metabolism 6, October 2007 ª2007 Elsevier Inc. 261
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from the fat body. In contrast, miR-278 mutants display
an opposite phenotype—lean animals with significantly
reduced TAG levels (Teleman et al., 2006). The authors
observed that dilp2, dilp3, and dilp5 are increased in
miR-278 mutants and found that removing one copy of
Dp110 (encoding the catalytic PI3K subunit) is sufficient
to alleviate most of the leanness associated with the
miR-278 mutation, suggesting that this phenotype is at
least partly due to increased insulin signaling. The miR-
278 mutants, however, also display increased levels of
circulating trehalose, suggesting they are insulin resistant,
similar to what is seen in patients with type 2 diabetes.
Consistent with this, insulin injection resulted in only mod-
est reduction of 4E-BPmRNA in the fat body (as a readout
of insulin signaling through FOXO), compared to a 3-fold
reduction seen in wild-type larvae. miR-278 thus appears
to play a role in appropriate insulin responsiveness. Our
understanding of these miRNAs, however, requires the
identification of their target transcripts, and Teleman
et al. (2006) provide evidence that miR-278 may act
through expanded, which encodes part of a membrane-
associated cell-signaling complex. The observation that
miRNAs regulate metabolism in other higher organisms
suggests that their ability to fine-tune metabolic
responses at the posttranscriptional level has been con-
served through evolution (Wilfred et al., 2007).
New Insights into the Regulation of Lipolysis
The larval fat body serves as a dynamic source for main-
taining energy homeostasis and as a requisite reservoir
for stored lipid during the prolonged period of nonfeeding
during metamorphosis. Accordingly, fat body lipid mass
rises to 15% the total weight of the animal in the third
instar, from 6% as a newly hatched first instar, most of
which can be attributed to TAG (Church and Robertson,
1966a, 1966b). The larval fat body in newly emerged
adults is replaced during the first few days by adult fat
cells, with adults maintaining 6.5% of their body weight
as lipid, similar to that seen in the first instar (Aguila et al.,
2007; Rizki, 1978; Teague et al., 1986). This shift in lipid
load is indicative of the change in fat body function, from
directing organismal growth and TAG storage during larval
stages to maintaining energy homeostasis in the adult
(Colombani et al., 2003; Rizki, 1978). Consistent with
this, the adult fat body is subject to diet-induced lipid over-
load, unlike the larval fat body, an observation that
establishes the adult fly as an ideal context for functional
studies of diet-induced obesity, a critical risk factor for
human disease (Bross et al., 2005; Sanchez-Blanco
et al., 2006).
One example of this is the naturally occurring adipose60
mutant, which displays increased levels of total lipid under
normal feeding conditions in the adult, with no effects at
earlier stages, along with significant starvation resistance
(Hader et al., 2003; Teague et al., 1986). The adipose gene
encodes a protein with WD40 repeats that is widely
expressed at all developmental stages and that can
decrease TAG when overexpressed in the larval fat body262 Cell Metabolism 6, October 2007 ª2007 Elsevier Inc.(Hader et al., 2003). This study also noted that orthologs
of Adipose are encoded by both the mouse and human
genomes and speculated that its role in lipid metabolism
may be conserved through evolution. Importantly, this
prediction was recently confirmed by Suh et al. (2007),
who showed that mice with one mutant copy of adipose
are obese and insulin resistant, while transgenic adipose
overexpression in fat results inmice that are lean and insu-
lin sensitive. Biochemical and cell culture studies indicate
that Adipose protein can bind histones and HDAC3 and
may function as part of a transcriptional corepressor
complex. Taken together, these studies demonstrate the
powerful predictive function of Drosophila genetics,
where genes discovered in the fly reveal new levels of
metabolic control that are conserved through evolution
to vertebrates.
Genetic analyses of two central players in lipid depo-
sition and mobilization have provided significant new
insights into the control of lipolysis. Characterization of
the Drosophila perilipin-like protein LSD2 (lipid storage
droplet 2) has demonstrated an evolutionary conserved
role for the lipid droplet-associated PAT-domain proteins
in promoting lipid storage (Gro¨nke et al., 2003; Teixeira
et al., 2003). Similarly, studies of the TAG lipase Brummer
foreshadowed the essential role of its vertebrate ortholog
ATGL in energy metabolism (Gro¨nke et al., 2005; Haem-
merle et al., 2006). Both LSD2 and Brummer reside on
the outer membrane of lipid droplets (Gro¨nke et al.,
2003, 2005). Mutant lsd2 animals exhibit a starvation-
sensitive lean phenotype, due to a severe reduction in
TAG, while lsd2 overexpression in the fat body increases
TAG storage in a dose-dependent manner, leading to
starvation resistance (Gro¨nke et al., 2003; Teixeira et al.,
2003). Conversely, the lipase activity of Brummer mobi-
lizes stored TAG.Mutants of brummer display progressive
obesity during early adult development, with no effects on
glycogen levels, while ectopic fat-body expression signif-
icantly depletes stored TAG (Gro¨nke et al., 2005). These
mutants are also starvation resistant, indicating that other
pathways exist to mobilize the stored energy in these
obese animals. The counterbalancing actions of these
two lipid droplet proteins can be seen in lsd2; brummer
doublemutants, which display normal TAG levels, demon-
strating their central role in modulating lipolysis (Gro¨nke
et al., 2005).
A recent study has addressed how insect AKH acts in
parallel with Brummer to regulate lipolysis, in addition to
the effects of AKH on sugar homeostasis described above
(Gro¨nke et al., 2007; Lee and Park, 2004). Similar to b-
adrenergic signaling in mammalian lipid mobilization,
AKH acts in an endocrine manner via the AKH receptor
(AKHR) to activate protein kinase A and initiate lipolysis.
Like lsd2 and brummer, akhr is expressed highly in the
fat body (Gro¨nke et al., 2007). Fat body-specific akhr over-
expression results in a significant reduction in TAG, while
akhr mutants accumulate lipid storage droplets and dis-
play increased TAG (Gro¨nke et al., 2007). Importantly,
the ability of chronic AKH overexpression to deplete lipid
stores has no effect in akhrmutants, indicating that all lipid
Cell Metabolism
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ble mutants for brummer and akhr show an additive effect
on lipid accumulation but are also starvation sensitive.
Measurement of TAG levels in these double mutants dem-
onstrated that their excess lipid reserves do not change
upon starving them to death. These starved mutants
can, however, access their carbohydrate stores, demon-
strating that this is not a general metabolic block but,
rather, that brummer and AKH define the major lipolytic
pathways in the animal. Further studies of starvation-in-
duced lipolysis in akhr and brummer mutants revealed at
least two distinct temporal phases, suggesting that AKH
acts early upon food deprivation while brummer acts as
the primary basal lipolytic factor and also upon prolonged
starvation.
Taken together, these pioneering genetic studies of
Drosophila lipid metabolism reveal the evolutionary con-
servation of perilipin and ATGL function as well as the dis-
tinct mechanisms by which Brummer and AKHR control
lipid mobilization in Drosophila. The relatively large num-
ber of putative lipases encoded by the fly genome (Table
S1), the regulation of many of these genes by starvation
(Gro¨nke et al., 2005; Zinke et al., 2002), and the similar
proteomic composition of fly and mammalian lipid drop-
lets (Cermelli et al., 2006), establish parallels between fly
and human lipid physiology and indicate that future stud-
ies in Drosophila will provide new insights into how lipid
homeostasis is maintained.
Sterol Absorption and Trafficking Defects in NPC
Pathology
Aside from its essential role in cell membranes, choles-
terol acts as the precursor for steroid hormones such as
the insect steroid ecdysone, which triggers the major de-
velopmental transitions in the life cycle (Thummel, 2001).
Although recent studies have defined many of the bio-
chemical steps by which cholesterol is converted into ec-
dysone (Rewitz et al., 2006), the mechanisms that control
cholesterol sensing, absorption, intracellular trafficking,
and homeostasis have remained unclear. Recent work
on the NPC proteins has offered insights into these pro-
cesses in the fly, with implications for understanding sterol
homeostasis in humans.
The NPC proteins were identified based on the abnor-
mal intracellular accumulation of lipids and cholesterol
seen in patients with mutations in NPC genes, defects
that eventually lead to neurodegeneration and death dur-
ing adolescence (Vance, 2006). Two genes in Drosophila,
npc1a,and npc1b, are similar to human NPC1 and its pa-
ralog NPC1L1, encoding proteins with a 13-pass trans-
membrane domain and a putative sterol-sensing region
(Fluegel et al., 2006; Huang et al., 2005). The midgut-re-
stricted expression pattern and function of npc1b mirror
that of NPC1L1 in the mouse, which is required specifi-
cally in the intestine for sterol absorption (Ioannou,
2007). Drosophila npc1b mutants die following a pro-
longed second instar larval stage and can be effectively
rescued by midgut-specific expression of a wild-type
transgene, supporting an essential role for npc1b in thistissue (Voght et al., 2007). Radiolabeled cholesterol feed-
ing experiments show that cholesterol absorption is re-
duced dramatically in these mutants. Consistent with
this, npc1b mutant midguts display virtually no staining
with the cholesterol-binding compound filipin. Total cho-
lesterol levels in npc1b mutants and filipin staining in pe-
ripheral tissues, however, both appear normal, indicating
that the critical function for this gene is in dietary choles-
terol absorption—an essential role for a cholesterol auxo-
troph such as Drosophila.
Studies of npc1a have shown that it is required for intra-
cellular sterol trafficking (Fluegel et al., 2006; Huang et al.,
2005). Null npc1a mutants display abnormal punctate fili-
pin staining throughout the animal, indicating subcellular
sterol accumulation and reflecting the widespread ex-
pression of npc1a. As a result, npc1a mutants die follow-
ing a prolonged first instar larval stage, a phenotype that
can be rescued by feeding excess cholesterol. Partial res-
cue can also be achieved by feeding ecdysone to mutant
larvae or expressing wild-type npc1a specifically in the
ring gland, demonstrating an essential role for this gene
in providing sufficient sterol precursors for steroidogene-
sis. Interestingly, although punctate filipin staining is
seen in human NPC patients, npc1a mutants display no
evidence of another hallmark of the disease, neurodegen-
eration, suggesting that this phenotype is not a primary
defect but rather may be a secondary consequence due
to low levels of neurosteroids—a proposal supported by
genetic studies ofNPC1 in mice (Griffin et al., 2004). More-
over, while molecular mechanisms for NPC1L1 have re-
mained unclear, studies of Drosophila npc1b mutants
suggest that the primary defect is sterol absorption by
the intestinal epithelium, although it may also play roles
in intracellular sterol trafficking (Voght et al., 2007). In ad-
dition to providing insights into NPC function in humans,
these genetic studies in Drosophila have established
a framework for studies of sterol homeostasis. For ex-
ample, larvae lacking both npc1a and npc1b retain the
ability to effectively absorb cholesterol, raising the inter-
esting possibility that there are alternate modes for sterol
uptake and suggesting that other factors may be discov-
ered that could impact NPC disease (Voght et al., 2007).
In addition, these Drosophila mutants provide invaluable
tools to manipulate cholesterol levels in vivo and, thus,
could be useful in future studies to uncover how sterol
levels are sensed in the animal and maintained during
development.
Why Study Metabolism in Drosophila?
Over the past two decades, genetic studies in Drosophila
have established the basis for our understanding of the
central regulatory mechanisms that control animal devel-
opment. Well-known signaling pathways, such as Notch,
wingless, and hedgehog, owe their discovery to Drosoph-
ila genetic screens and have had profound implications for
our understanding of vertebrate development as well as
the origins of human disease (Bier, 2005). The past few
years have seen a shift in direction, in which Drosophila
is being increasingly exploited to understand theCell Metabolism 6, October 2007 ª2007 Elsevier Inc. 263
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Reviewfundamental mechanisms that control metabolism. As
with our use of the fly to study development, these genetic
efforts provide a unique opportunity to uncover critical
new insights into central regulatory pathways that are con-
served through evolution and have direct implications for
the origin and treatment of human disease risk factors,
such as diabetes and obesity. Indeed, even the relatively
few Drosophila papers described in this review have
changed our understanding of vertebrate metabolic con-
trol. For example, contrary to studies in mammalian cell
culture, 4E-BP regulates organismal lipid homeostasis
rather than growth (Teleman et al., 2005a). Similarly, the
discovery of evolutionarily conserved essential regulators
of lipid metabolism in Drosophila, such as melted and
adipose, provide new directions for understanding the
control of these pathways in humans and, also, raise the
possibility that mutations in these genes may be risk fac-
tors for humanmetabolic disorders. The first genetic study
of an essential enzyme in organismal lipolysis, the ATGL
homolog Brummer, foreshadowed genetic studies of its
vertebrate counterpart inmice (Gro¨nke et al., 2005; Haem-
merle et al., 2006). Similarly, the extreme lipolytic disorder
seen in brummer, akhr double mutants has not yet been
approached in mouse models (Gro¨nke et al., 2007). In
addition, as pointed out by Huang et al. (2005), contrary
to the proposal that lipid accumulation is a cause of
NPC pathology, sterol shortage should instead be consid-
ered as a possible primary defect, a conclusion that has
radical implications for the current use of lower cholesterol
levels as part of NPC disease treatment.
The ability to manipulate the fly genome in virtually any
way desired, combined with a range of newly available
genomic resources, allow the researcher to define the
molecular mechanisms of gene function at a level of
resolution not possible in more complex organisms. In
addition, no studies to date have exploited one of the
main strengths of Drosophila—the ability to conduct
large-scale open-ended genetic screens—an approach
that holds the promise of extending our understanding
of metabolic regulation in new and unexpected directions.
It is likely that we have much to look forward to in the next
few years, as further studies exploit the humble fruit fly to
reveal new insights into the regulation of metabolism and
homeostasis.
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